Belite Bio (BLTE) Interest & Investment Income (2024 - 2025)
Belite Bio (BLTE) recorded quarterly Interest & Investment Income of $3.5 million in Q3 2025, up 243.78% quarter-over-quarter from -$2.4 million in Q3 2024, and up 243.78% on a YoY basis from $1.0 million in Q3 2024.
Belite Bio (BLTE) Interest & Investment Income (2024 - 2025) Analysis & Trends
Belite Bio's Interest & Investment Income history runs 2 years deep, the most recent figure standing at $3.5 million for Q3 2025.
- In Q3 2025, Interest & Investment Income rose 243.78% year-over-year to $3.5 million; the TTM figure through Sep 2025 stood at $3.5 million (up 243.78% YoY), while the FY2025 annual figure was $6.6 million, up 77.68% from the prior year.
- Interest & Investment Income was $3.5 million for Q3 2025 at Belite Bio, up from -$2.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.5 million in Q3 2025 to a low of -$2.4 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.47 Mn |
| Sep 30, 2024 | -2.41 Mn |